| The influence of mammographic density on breast tumor characteristics. | |
| | |
MedLine Citation:
|
PMID: 22710708 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Mammographic density (MD) is a well-established risk factor for breast cancer. Whether MD influences the tumor phenotype remains to be clarified. Previous studies are highly inconsistent and most lack important covariate information. This is a case-only study within a population-based case-control study. Cases were all postmenopausal women, aged 50-74 years, with incident breast cancer, diagnosed 1993-1995, and with no history of previous cancer (n = 2,720). 1,747 women with mammograms and information on tumor characteristics were included in analyses. MD was assessed using a computer-assisted thresholding technique. We used linear, logistic, and multinomial logistic regression, adjusting for possible confounders, to study density and tumor characteristics. PD was only statistically significantly associated with tumor size in our study (regression coefficient 0.031, p = 0.017). The effect of PD on tumor size was greater when mode of detection was excluded from the model (regression coefficient 0.043, p = 0.001). No other associations between PD and the tumor characteristics studied (lymph node metastasis, ER-status, PR-status, grade, and histopathological classification) were observed. In summary, PD was positively associated with tumor size in postmenopausal women. However, the relationship was at least partially confounded by mode of detection. Although there may be a true biological relationship between MD and more highly proliferative tumors, it also seems that part of this relationship is due to masking delaying diagnosis. In conclusion, PD does not seem to be differentially associated with tumor phenotype, except for tumor size, after taking mode of detection into consideration. |
| | |
Authors:
|
Louise Eriksson; Kamila Czene; Lena Rosenberg; Keith Humphreys; Per Hall |
Related Documents
:
|
22273468 - Cardiac paraganglioma: diagnostic and surgical challenges. 22488918 - Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in... 16758188 - Enhanced inhibitory effect of the matrix metalloproteinase inhibitor ro 28-2653 in comb... 22348248 - Imaging molecular pathways: reporter genes. 3141048 - Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione... 12576868 - Connexin 26 is abnormally expressed in bladder cancer. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-6-19 |
Journal Detail:
|
Title: Breast cancer research and treatment Volume: - ISSN: 1573-7217 ISO Abbreviation: - Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-6-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8111104 Medline TA: Breast Cancer Res Treat Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Institution of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels Väg 12 A, 171 77, Stockholm, Sweden, Louise.eriksson@ki.se. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Long-term survival of older breast cancer patients: population-based estimates over three decades.
Next Document: Cardiometabolic factors and breast cancer risk in U.S. black women.